Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables surgical procedures using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic endoluminal procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. Intuitive Surgical, Inc. was incorporated in 1995 and is headquartered in Sunnyvale, California.

Intuitive Surgical Inc.

Intuitive Surgical ($ISRG) announced an update on their ongoing clinical study. This new study from Intuitive Surgical focuses on a device upgrade ...

Intuitive Surgical’s New Force Feedback Trial Could Sharpen Its Robotic Edge in Cardiac Surgery

The Strategy Shares Monopoly ETF (MPLY) is an actively managed fund that owns the U.S. equities Strategy Shares believes demonstrate durable compet...

Ten Structural Traits That Define a Monopoly: Inside the Screen Behind the Strategy Shares Monopoly ETF (MPLY)

Piper Sandler analyst Adam Maeder reiterated a Buy rating on Intuitive Surgical today and set a price target of $580.00. Maeder covers the Healthca...

Piper Sandler Sticks to Their Buy Rating for Intuitive Surgical (ISRG)

Humanoid robotics is becoming a bigger theme for investors watching AI, defense tech, and automation. Foundation Future Industries, a San Francisco...

Foundation’s War Robots Put AI and Defense Stocks Back in Focus

The latest announcement is out from Intuitive Surgical ( ($ISRG) ). On May 28, 2026, Intuitive announced that Taylor Patton, currently global senio...

Intuitive Surgical Names New Chief Commercial and Marketing Officer

In a report released today, Larry Biegelsen from Wells Fargo maintained a Buy rating on Intuitive Surgical, with a price target of $654.00. Biegels...

Wells Fargo Reaffirms Their Buy Rating on Intuitive Surgical (ISRG)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Denali Therapeutics (DNLI) and Intuitive Surgical (I...

Current Quarter	$2.02	Next Quarter	$2.12
Current Year	$8.57	Next Year	$9.81
QoQ Growth	+5.0%	YoY Growth	+14.5%
3Y EPS CAGR	+29.1%	Target Price	$577.96
Consensus	Buy	Upside	+42.1%

Current Quarter Rev	N/A	Next Quarter Rev	N/A
Revenue Growth	N/A	YoY Growth	N/A

	A	B	C	D
1	Symbol	Price	Change	Volume
2	ISRG	$406.78	+1.14%	4.40M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	ISRG	$406.78	+1.1%	4.40M
3
4
5
6

ISRG

ISRG

EPS Estimates Overview

EPS Historical Trend (5 Years)

Quarterly EPS Estimates

Revenue Analysis

Get Intuitive Surgical Inc. Data in Excel

Get Intuitive Surgical Inc. Data in Excel